Cu64 has a longer 1/2 life than the others so it floats through the body longer. That means it doesn’t die like the other isotopes before most of it attaches to the cancer.
This means more concentration of the isotope and of course a friggen Xmas tree lighting up on the scan
CU6 could stop at one day if they wanted to… like the others
BUT
the Image is not good enough.
Soooo
they want to scan the next day….
because it is a better image.
(and then of course you send in the CU67 Calvary)
CU6 have this option, it’s better and you can’t rush the isotope to swim quicker in a body…can you?
The competitors of CU6 don’t have this option because their “wonder” isotope dies too quickly (*wonderish IMHO).
The competitors are flogging something that is inferior to what we have (and are developing) and it seems people here are saying waiting a day to get it right and see shiiteloads more treatable cancer….is a pain.
BULLOCKS!!!
The Pain is not getting rid of it:
Simple.
- Forums
- ASX - By Stock
- Ann: Head-to-head IIT with SAR-bisPSMA
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
5.44%
!
$2.52

Cu64 has a longer 1/2 life than the others so it floats through...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.52 |
Change
0.130(5.44%) |
Mkt cap ! $810.1M |
Open | High | Low | Value | Volume |
$2.39 | $2.54 | $2.37 | $5.141M | 2.072M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6820 | $2.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.52 | 3500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 405 | 2.500 |
1 | 20000 | 2.480 |
4 | 41204 | 2.450 |
1 | 5000 | 2.410 |
5 | 3695 | 2.400 |
Price($) | Vol. | No. |
---|---|---|
2.520 | 3500 | 1 |
2.540 | 37102 | 3 |
2.550 | 30520 | 6 |
2.580 | 30000 | 2 |
2.590 | 10004 | 2 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online